The 2014 NCCN Case Manager and Medical Director Program consists of five presentations on the topics of biomarkers and targeted therapies, breast cancer, cancer survivorship, clinical trials and drug compendia, and pancreatic cancer. This educational series is designed to help case managers and medical directors that are interested in learning more about the current state of the art in oncology care manage patients with cancer based on evidence and according to the recommendations in the NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines®).

Intended Audience
These activities are designed to meet the educational needs of oncology nurses, case managers, nurses in other roles (i.e., quality management and utilization review), and medical directors at managed care organizations, reinsurers, TPAs, case management, and disease management companies who interact with, counsel, and refer patients with cancer to appropriate sources of care.

Accreditation
These activities are approved for AMA PRA Category 1 Credit(s)™. These activities have been pre-approved by the Commission for Case Manager Certification to provide continuing education credit to Certified Case Managers (CCMs) and nursing credits are provided as well. Complete accreditation information is provided before each individual educational activity.

Fee Information
There is no fee for these educational activities.

Supporters
These activities are supported by educational grants from:  

• Astellas Scientific and Medical Affairs, Inc.
• CELGENE CORPORATION
• Genentech
• Lilly
• Novartis Oncology